Sign In
Buy MOH
$200.34
+0.86 (+0.431%)
At Close: Jul 28, 2026
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
03:00pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Humana: Consider Buying A Dip In Health Insurer Stock, But Volatility Likely
02:32pm, Thursday, 10'th Mar 2022 Investing.com
Should iShares Core S&P MidCap ETF (IJH) Be on Your Investing Radar?
11:20am, Thursday, 10'th Mar 2022 Zacks Investment Research
Style Box ETF report for IJH
Molina Healthcare Announces First Quarter 2022 Earnings Release and Conference Call Dates
04:15pm, Monday, 07'th Mar 2022
LONG BEACH, Calif.--(BUSINESS WIRE)---- $MOH--Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the first quarter ended March 31, 2022. Molina Healthcare w
Should SPDR S&P MidCap 400 ETF (MDY) Be on Your Investing Radar?
11:20am, Thursday, 03'rd Mar 2022 Zacks Investment Research
Style Box ETF report for MDY
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
11:20am, Wednesday, 02'nd Mar 2022 Zacks Investment Research
Smart Beta ETF report for FXH
Molina (MOH) to Join S&P 500 Driven by Medicare Performance
05:01pm, Monday, 28'th Feb 2022 Zacks Investment Research
Molina Healthcare (MOH) is likely to leave S&P MidCap 400 and replace IHS Markit Ltd. in the S&P 500 Index.
Molina (MOH) to Join S&P 500 Driven by Medicare Performance
01:47pm, Monday, 28'th Feb 2022
Molina Healthcare (MOH) is likely to leave S&P MidCap 400 and replace IHS Markit Ltd. in the S&P 500 Index.
Molina Healthcare to join the S&P 500 index
10:30pm, Friday, 25'th Feb 2022 MarketWatch
S&P Dow Jones Indices said late Friday that Molina Healthcare Inc. will join the S&P 500 index , replacing IHS Markit Ltd , which is being acquired by S&P Global Inc. , an S&P 500 constituent. Energy company Range Resources Corp. will replace Molina Healthcare in the S&P MidCap 400. The changes are effective Wednesday before the bell. The IHS Markit deal is expected to be completed Monday. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Molina Healthcare Set to Join S&P 500; Range Resources to Join S&P MidCap 400; Golden Entertainment to Join S&P SmallCap 600
10:15pm, Friday, 25'th Feb 2022 S&P Global Platts
NEW YORK, February 25, 2022: S&P MidCap 400 constituent Molina Healthcare Inc. (NYSE:MOH) will replace IHS Markit Ltd (NYSE:INFO) in the S&P 500, S&P SmallCap 600 constituent Range Resources Corp. (NYSE:RRC) will replace Molina Healthcare in the S&P MidCap 400, and Golden Entertainment Inc. (NASD:GDEN) will replace Range Resources in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, March 2. S&P 500 constituent S&P Global Inc. (NYSE: SPGI) is acquiring IHS Markit in a transaction expected to be completed on February 28.
Molina Healthcare to join the S&P 500 index
05:30pm, Friday, 25'th Feb 2022
S&P Dow Jones Indices said late Friday that Molina Healthcare Inc. MOH, +3.52% will join the S&P 500 index SPX, +2.24% , replacing IHS Markit Ltd INFO, +0.74% , which is being acquired by S&P Global I
Integra's (IART) Q4 Earnings Top Estimates, Gross Margin Drops
03:40pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Integra (IART) records strong recovery in order demand in Q4 on broad-based strength in Neurosurgery and sales from the company's new CereLink ICP monitoring.
Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y
04:10pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.
Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates
04:07pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Despite reporting a fourth-quarter loss, Glaukos' (GKOS) results reflect a noticeable rise in revenues.
Exact Sciences (EXAS) Q4 Revenues Top Estimates, Margin Down
12:53pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Exact Sciences' (EXAS) legacy Screening business saw strong momentum on solid Cologuard volume growth during the fourth quarter.
